Novel Genes Associated with the Development of Carotid Paragangliomas
- Authors: Snezhkina A.V.1, Lukyanova E.N.1, Fedorova M.S.1, Kalinin D.V.2, Melnikova N.V.1, Stepanov O.A.1,3, Kiseleva M.V.3, Kaprin A.D.3, Pudova E.A.1, Kudryavtseva A.V.1
-
Affiliations:
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
- Vishnevsky Institute of Surgery, Ministry of Health of the Russian Federation
- National Medical Research Radiological Center, Ministry of Health of the Russian Federation
- Issue: Vol 53, No 4 (2019)
- Pages: 547-559
- Section: Genomics. Transcriptomics
- URL: https://journal-vniispk.ru/0026-8933/article/view/164013
- DOI: https://doi.org/10.1134/S0026893319040137
- ID: 164013
Cite item
Abstract
Carotid paragangliomas (CPGLs) are rare neuroendocrine tumors of the head and neck. “Germline” and somatic mutations in a number of genes were shown to be associated with the development of CPGLs; however, molecular mechanisms of the tumor pathogenesis have not been fully understood. In the work, we have used whole exome sequencing data of 52 CPGLs obtained earlier. Using MutSigCV, the search for genes with high mutation rate was performed. Thirty four genes (MADCAM1, SARM1, ZFPM1, CTDSP2, DSPP, POTED, ANP32B, FRG2B, BAGE3, CCDC89, ACOT2, KRTAP10-1, ATXN1, GXYLT1, MUC2, AQP7, TMPRSS13, KRTAP4-3, PRR21, PSPH, PLBD1, ZNF595, IGSF3, PRR16, FAM157A, KCNJ12, HYDIN, IGFBP2, KIAA1671, DISC1, MUC6, XKR3, HRNR, and MUC4) potentially associated with the CPGL initiation and progression were revealed. The involvement of these genes in the pathogenesis of CPGLs was first shown, and possible mechanisms of their participation in that were discussed.
About the authors
A. V. Snezhkina
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Author for correspondence.
Email: leftger@rambler.ru
Russian Federation, Moscow, 119991
E. N. Lukyanova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Email: leftger@rambler.ru
Russian Federation, Moscow, 119991
M. S. Fedorova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Email: leftger@rambler.ru
Russian Federation, Moscow, 119991
D. V. Kalinin
Vishnevsky Institute of Surgery, Ministry of Health of the Russian Federation
Email: leftger@rambler.ru
Russian Federation, Moscow, 117997
N. V. Melnikova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Email: leftger@rambler.ru
Russian Federation, Moscow, 119991
O. A. Stepanov
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences; National Medical Research Radiological Center, Ministry of Health of the Russian Federation
Email: leftger@rambler.ru
Russian Federation, Moscow, 119991; Moscow, 125284
M. V. Kiseleva
National Medical Research Radiological Center, Ministry of Health of the Russian Federation
Email: leftger@rambler.ru
Russian Federation, Moscow, 125284
A. D. Kaprin
National Medical Research Radiological Center, Ministry of Health of the Russian Federation
Email: leftger@rambler.ru
Russian Federation, Moscow, 125284
E. A. Pudova
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Email: leftger@rambler.ru
Russian Federation, Moscow, 119991
A. V. Kudryavtseva
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Email: leftger@rambler.ru
Russian Federation, Moscow, 119991
Supplementary files
